Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Cancer|December 20, 2002
Phase II study of cladribine and cyclophosphamide in patients with chronic lymphocytic leukemia and prolymphocytic leukemiaMarco Montillo, Alessandra Tedeschi, Susan O'Brien, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2005
Renal vascular response to static handgrip exercise: sympathetic vs. autoregulatory controlAfsana Momen, Douglas Bower, Urs A Leuenberger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Phase I trial of nelarabine in indolent leukemiasVarsha Gandhi, Constantine Tam, Susan O'Brien, et al.
Clinical Transplantation|March 14, 2019
Higher rates of rejection in HIV-infected kidney transplant recipients on ritonavir-boosted protease inhibitors: 3-year follow-up studyBrett Rollins, Samira Farouk, Graciela DeBoccardo, et al.
Leukemia & Lymphoma|August 10, 2011
Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemiaJohn Hornberger, Carolina Reyes, Ashwini Shewade, et al.
Cancer|March 29, 2002
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative diseaseFrancesco DiRaimondo, Maher Albitar, Yang Huh, et al.
Leukemia & Lymphoma|October 30, 2009
p53 expression by immunohistochemistry is an important determinant of survival in patients with chronic lymphocytic leukemia receiving frontline chemo-immunotherapyEllen J Schlette, Joan Admirand, William Wierda, et al.
Cancer|January 1, 2009
Chemoimmunotherapy may overcome the adverse prognostic significance of 11q deletion in previously untreated patients with chronic lymphocytic leukemiaApostolia-Maria Tsimberidou, Constantine Tam, Lynne V Abruzzo, et al.
Leukemia & Lymphoma|October 6, 2007
The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathyConstantine S Tam, Susan O'Brien, Susan Lerner, et al.
Pageof 7